Taeyoon Jung | Biochemical Pharmacology | Research Excellence Award

Dr. Taeyoon Jung | Biochemical Pharmacology | Research Excellence Award

University of Washington | United States

Dr. Taeyoon Jung is a medicinal chemist and trained pharmacist with strong expertise in drug metabolism and pharmacokinetics (DMPK), integrating experimental and computational approaches to advance drug discovery and safety evaluation. He earned his PhD in Medicinal Chemistry from the University of Washington, following an MS in Drug Evaluation and a PharmD from Chungnam National University. His academic and professional experience spans leading research universities and industry, including graduate research roles in medicinal chemistry, pharmacology, and molecular toxicology, as well as a DMPK graduate internship in a global biopharmaceutical company. Dr. Jung’s research focuses on hydrogen sulfide signaling in cardiac and hepatic stress models, species-dependent drug metabolism, toxicology of bioactivated metabolites, and structure–function relationships of metabolic enzymes. He is highly skilled in LC-MS/MS-based metabolite quantification, in vitro ADME systems, cell-based and molecular assays, and advanced computational modeling such as molecular docking, molecular dynamics, and metadynamics for inhibitor design. His work has contributed to multiple peer-reviewed publications in drug metabolism and toxicology. In recognition of his scientific excellence, he has received several competitive scholarships, endowed funds, and presentation awards. Overall, Dr. Jung’s interdisciplinary background bridges chemistry, pharmacology, and computation, positioning him as a versatile researcher dedicated to improving drug safety and therapeutic development.

View ORCID Profile

Featured Publications

Weikai Zhang | Drug Discovery | Research Excellence Award

Dr. Weikai Zhang | Drug Discovery | Research Excellence Award

Luoyang Polytechnic, China

Dr. Weikai Zhang is a dedicated biomedical engineering researcher whose work centers on advancing single-cell technologies for improved antibody discovery and biomedical applications. He earned his PhD in Biomedical Engineering from the School of Life Science at the Beijing Institute of Technology, preceded by a Master’s degree from Henan University of Science and Technology and a Bachelor’s degree in Biotechnology from Xinyang Agricultural College. His academic journey included extensive joint master’s and doctoral research at the National Center for Nanoscience and Technology, where he investigated nanobiological effects and safety. Earlier in his career, he contributed as a technician in the Antibody Engineering Laboratory at the National Protein Science Center in Beijing, gaining foundational expertise in protein science and antibody development. Currently, he serves as a Lecturer and Deputy Director of the Key Engineering Technology Research Center for Immune Technology Biological Materials Preparation in Henan Province. His research focuses on designing and developing microfluidic chips for single-cell analysis, improving throughput and screening efficiency, and enhancing diagnostic and therapeutic antibody development. Recognized for his scientific contributions, he has received multiple honors, including youth talent awards and innovation recognitions. Dr. Zhang continues to advance impactful research in biomedical engineering and single-cell technology.

Profile: Orcid

Featured Publications

Zhang, W., Li, Q., Jia, F., Hu, Z., & Wei, Z. (2021). “A microfluidic chip for screening and sequencing of monoclonal antibody at a single-cell level.” Analytical Chemistry. https://doi.org/10.1021/acs.analchem.1c00918